Myomo MYO 深 滬
等待開盤 09-23 09:30:00 美东时间
1.64
+0.070
+4.46%
華盛通- 最 高1.71
- 今 開1.55
- 成交量 60.37万股
- 最 低 1.5303
- 昨 收 1.57
- 總市值 6495.69万
- 52周最高 1.885
- 市盈率 靜 --
- 換手率 1.52%
- 52周最低 0.605
- 委 比 51.69%
- 總股本 3960.79万
- 歷史最高 695.88
- 量 比 1.15
- 振 幅 11.45%
- 歷史最低 0.369
- 每 手 1
- 風險率 0.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Myomo Q2 2026 Earnings Call Transcript
Myomo (AMEX:MYO) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultation. The full ear...
09-18 14:49
美股大行评级 | 潜在涨幅1024.26%！Ascendiant Capital上调PAVmed目标价至57美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持PAVmed"买入"评级，目标价从56美元升至57美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从9.25美元升至9.5美元
08-28 16:15
Ascendiant Capital Maintains Buy on Myomo, Raises Price Target to $10.5
Ascendiant Capital analyst Edward Woo maintains Myomo (AMEX:MYO) with a Buy and raises the price target from $10 to $10.5.
08-27 19:37
Myomo Sees Q3 Sales $11.500M-$12.000M vs $11.168M Est
Myomo (AMEX:MYO) sees Q3 sales of $11.500 million-$12.000 million vs $11.168 million analyst estimate.
08-06 04:34
美股大行评级 | 存储再获看多！美光、闪迪、西部数据获机构上调目标价；次新股Cerebras、Blackstone、EagleRock获多家机构首予买入平均
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从5.25美元升至5.5美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从9美元升至9.25美元
06-09 11:33
Ascendiant Capital Maintains Buy on Myomo, Raises Price Target to $10
Ascendiant Capital analyst Edward Woo maintains Myomo (AMEX:MYO) with a Buy and raises the price target from $9.5 to $10.
06-08 18:02
Myomo Affirms FY2026 Sales Guidance of $43.000M-$46.000M vs $48.591M Est
Myomo (AMEX:MYO) affirms FY2026 sales outlook from $43.000 million-$46.000 million to $43.000 million-$46.000 million vs $48.591 million estimate.
05-08 04:13
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Zevra Therapeutics (NASDAQ:ZVRA) stock moved upwards by 20.6% to $11.0...
03-10 05:05
Myomo Signs Agreement With Elevance Health Over Commercial, Medicare Advantage, Medicaid Plans; Expand Myomo's MyoPro Powered Arm And Hand Orthoses
Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced today it has
03-10 04:16
Earnings Breakdown: Myomo Q4
Myomo (AMEX:MYO) announced its Q4 earnings on Monday, March 9, 2026 at 04:06 PM...
03-10 04:08
